Summary of CCLGP1100 Immunofluorescence Quantitative Analyzer

Product Overview

CCLGP1100 (Getein1100) is a portable quantitative immunofluorescence point‑of‑care testing analyzer, designed for rapid clinical quantitative detection for multiple disease markers.

Main Features

1. Hardware & Operation System
   ‑ 7‑inch touch screen running Android OS; supports RFID‑card calibration, handwriting input, USB keyboard‑mouse connection; built‑in thermal printer.
   ‑ Ports: test‑card slot, SD‑card slot, USB port. Optional lithium‑battery supports 3‑hours continuous testing.
   ‑ Two operation workflows: automatic sample‑transfer mode; manual timing‑reaction mode.
   ‑ Weight 2.0 kg; dimension 261 × 241 × 115 mm; stores up to 10 000 test results.
   ‑ Multi‑language: Chinese, English, Spanish, Portuguese.
2. Performance
   ‑ Testing methodology: immunofluorescence quantitative assay.
   ‑ Turnaround time: 3‑15 minutes per test depending on items; supports multiple‑test rapid processing.
   ‑ Multiple‑quality‑control mechanisms.
   ‑ Acceptable specimens: whole blood, plasma, serum, urine, stool, nasal swab, saliva, capillary blood.
3. Power & Environment
   ‑ Power: 100‑240 V AC, 50/60 Hz, 60 VA.
   ‑ Working environment: temperature 10‑35 ℃; relative humidity ≤70 %; atmospheric pressure 70.0‑106.0 kPa.

Main Test Menu

‑ Cardiac & Coagulation markers: cTnI, TnT, BNP, NT‑proBNP, multiple myocardial‑combined panels, H‑FABP, CK‑MB, D‑Dimer; for myocardial infarction, heart failure, thromboembolism.
‑ Inflammation markers: hs‑CRP+CRP, PCT, PCT/CRP, SAA, SAA/CRP, IL‑6; for bacterial/viral infection, sepsis, acute‑inflammatory assessment.
‑ Renal‑function markers: CysC, mAlb, NGAL, β2‑MG; for acute/chronic kidney injury and nephropathy evaluation.
‑ Diabetes: HbA1c for diabetes diagnosis.
‑ Metabolic marker: 25‑OH‑VD for osteoporosis and osteomalacia.
‑ Thyroid‑function markers: TSH, T3, T4, fT3, fT4 for thyroid‑dysfunction screening.